Treatments for stage 2 rectal cancer
The following are treatment options for stage 2 rectal cancer. Your healthcare team will suggest treatments based on your needs and work with you to develop a treatment plan.
Radiation therapy is almost always offered for stage 2 rectal cancer. It may be given alone or as part of chemoradiation. External beam radiation therapy is the most common type of radiation used, but brachytherapy may be used in some cases.
Radiation therapy alone may be given before surgery (called neoadjuvant radiation therapy) if the tumour is in the upper part of the rectum and it is not attached to surrounding tissues (called a non-fixed tumour). Five treatments of radiation therapy may be given. This is sometimes called a short course of radiation.
If someone can’t have chemotherapy, radiation therapy alone may be used to treat a tumour in the lower part of the rectum, close to the fat tissue around the rectum (called mesorectum) or attached to surrounding tissues (called a fixed tumour). A long course of radiation therapy is used, which is given as 25–30 treatments.
Sometimes radiation therapy alone is given after surgery (called adjuvant radiation therapy).
Chemoradiation combines chemotherapy with radiation therapy. Chemotherapy is given during the same time period as radiation therapy. Some types of chemotherapy make radiation therapy more effective.
Chemoradiation may be given before surgery (called neoadjuvant chemoradiation) if the tumour is in the lower part of the rectum, if it is close to the fat tissue around the rectum (mesorectum) or if it is attached to surrounding tissues (called a fixed tumour). It is usually given as 25–30 treatments of radiation therapy (called a long course of radiation) and chemotherapy with 5-fluorouracil (Adrucil, 5-FU) or capecitabine (Xeloda) given for 5–6 weeks.
Chemoradiation may be given after surgery (called adjuvant chemoradiation). Chemoradiation is not given after surgery very often because neoadjuvant radiation therapy or neoadjuvant chemoradiation has become standard.
Surgery is the main treatment for stage 2 rectal cancer. A bowel resection is the type of surgery usually done. Depending on the location of the tumour, the surgeon may do a low anterior resection or abdominoperineal resection with total mesorectal excision. If the surgeon does a low anterior resection, the remaining 2 ends of the colon are joined together (called anastomosis).
Surgery is usually done 7–10 days after a short course of radiation therapy alone or 4–10 weeks after a long course of radiation therapy (given as part of chemoradiation).
Depending on the type of surgery done, the surgeon may need to do a temporary or permanent colostomy or ileostomy.
Chemotherapy may be given alone after surgery (called adjuvant chemotherapy). If neoadjuvant radiation therapy or chemoradiation was not used, adjuvant chemotherapy is usually given in addition to adjuvant chemoradiation.
Adjuvant chemotherapy is usually given for 4–6 months, but the length of chemotherapy depends on the amount of radiation or chemoradiation used before surgery.
The drugs used in adjuvant chemotherapy for stage 2 rectal cancer include:
- capecitabine (Xeloda)
- FOLFOX – leucovorin (folinic acid), 5-fluorouracil (Adrucil, 5-FU) and oxaliplatin (Eloxatin)
- 5-fluorouracil (Adrucil, 5-FU) with leucovorin (folinic acid)
- CAPOX (also called XELOX) – capecitabine (Xeloda) and oxaliplatin (Eloxatin)
Capecitabine (Xeloda) and FOLFOX are used most often as adjuvant chemotherapy.
You may be asked if you want to join a clinical trial for rectal cancer. Find out more about clinical trials.